{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-066601","form_type":"8-K","ticker":"ABT","cik":"0000001800","company_name":"ABBOTT LABORATORIES","filed_at":"2026-10-21T11:36:13+00:00","discovered_at":"2026-10-21T11:40:00.300741+00:00","generated_at":"2026-10-21T11:40:06.425578+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Abbott Q3 2026 sales up 14.5% reported, 7.0% comparable; adjusted EPS $1.42; FY guidance tightened to $5.50-$5.55","bullets":["Total company third-quarter sales were $13.01 billion, up 14.5% reported and 7.0% comparable, with U.S. sales up 28.0% to $5.50 billion.","GAAP diluted EPS was $0.53 versus adjusted diluted EPS of $1.42; full-year 2026 adjusted EPS guidance reaffirmed at midpoint and narrowed to $5.50-$5.55.","Diagnostics sales jumped 46.7% reported to $3.31 billion, driven by the March 23, 2026 Exact Sciences acquisition and 13.8% comparable Cancer Diagnostics growth.","Medical Devices sales rose 6.9% to $5.83 billion, led by 15.0% growth in Electrophysiology; Diabetes Care CGM sales grew 7.3% reported.","Abbott cited FDA approval of Libre Duo, CE Mark for Amulet 360, FDA approval of TactiFlex Duo and launch of SimpleScreen CRC; Q4 adjusted EPS guided to $1.62-$1.67."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-066601","json":"https://secwatch.observer/filing/0001628280-26-066601.json","markdown":"https://secwatch.observer/filing/0001628280-26-066601.md","text":"https://secwatch.observer/filing/0001628280-26-066601.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800/000162828026066601/0001628280-26-066601-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800/000162828026066601/abt-20261021.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-21T11:40:06.425578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}